click below
click below
Normal Size Small Size show me how
Repro Flash Cards
Ch 14 Reproductive Drugs - Flash Cards (Paradigm)
| Term | Definition |
|---|---|
| masculinizing hormone therapy | the use of hormone therapy to induce the development of typically masculine secondary sex characteristics in a person who was assigned female at birth |
| menopause | describes the time when the menstrual cycle stops for one year, usually marking the end of reproductive years |
| transdermal contraceptive | a stick-on patch that delivers a combination of estrogen and progesterone in a steady supply through the skin |
| cervical cap | a contraceptive device inserted inside the vagina that fits over the cervix to prevent sperm from entering the uterus |
| melasma | patches of darkened skin on the face |
| intrauterine device | a contraceptive device placed into the uterus by a healthcare practitioner; it stays in place for up to 10 years |
| growth hormone–releasing factor | a neuropeptide secreted by the hypothalamus that stimulates the secretion of growth hormone by the pituitary |
| progesterone | the hormone that prepares the uterus for a fertilized ovum |
| nonvirilized | lacking typically male secondary sex characteristics despite having been born with testes |
| erectile dysfunction | a chronic inability to achieve a penile erection or to maintain one until ejaculation |
| testosterone | an androgen that is responsible for sperm production, sexual potency, and the maintenance of muscle mass and strength, among other functions |
| progestin | any of a group of synthetic hormones that emulate the effects of progesterone |
| transgender | having a gender identity that differs from the sex a person was assigned at birth, which is typically limited to male or female |
| human chorionic gonadotropin | a glycoprotein produced by trophoblastic cells and their descendants in the placenta |
| oxytocic agent | a drug that promotes contraction of uterine smooth muscle at term of pregnancy |
| emergency contraceptive | a drug taken within 120 hours of having sex that stops the release of an egg from the ovary to prevent fertilization by sperm; if the patient is already pregnant, the drug has no effect |
| vaginal ring | a combination contraceptive that is inserted into the vagina; contains synthetic estrogen and progesterone |
| vasomotor | affecting constriction and dilation of blood vessels |
| growth hormone deficiency | a condition in which the pituitary gland doesn’t produce enough growth hormone, which leads to stunted height, stunted muscle development, or both |
| sexual dysfunction | persistent, recurrent problems with sexual response, including decreased desire, reduced arousal, inability to achieve orgasm, and pain during sexual intercourse |
| oral contraceptive | one or more hormonal compounds taken orally to prevent the occurrence of pregnancy |
| growth hormone | a fundamental hormone that affects metabolism, skeletal growth, and somatic growth; a deficiency in this hormone causes growth retardation |
| perimenopause | a period of time prior to menopause, characterized by a gradual loss of ovarian function and irregular bleeding |
| gender transition | a process that is social, physical, or both that seeks to align a person’s gender identity with their outward appearance; it may include hormone therapy and other medical interventions |
| tocolytic agent | a drug that slows labor in pregnancy; used to treat premature labor |
| androgen | any of a group of hormones that promote the development and maintenance of typically masculine physical characteristics |
| virilization | the development of typically masculine secondary sex characteristics |
| phytoestrogen | a plant source of protein and fiber used in complementary and alternative medicine for conditions including hot flashes; also known as isoflavone and soy |
| spermicide | an agent that kills sperm cells on contact |
| hormone therapy | treatment to relieve symptoms of a deficiency in sex hormones, to augment sexual characteristics, or to support gender identity and transition; also known as hormone replacement therapy |
| hypogonadism | a condition in which the body’s sex glands produce few or no hormones |
| feminizing hormone therapy | a reduction of androgen activity and use of hormone therapy to induce the development of typically secondary sex characteristics in a person who was assigned male at birth |
| gynecomastia | excessive development of mammary glands, with or without tenderness |
| contraception | any practice that serves to prevent pregnancy during sexual activity |
| dyspareunia | painful intercourse |
| endometrium | the inner membrane of the uterus |
| diaphragm | a contraceptive device inserted inside the vagina to prevent sperm from entering the uterus |
| internal condom | a condom inserted into the vagina before sexual activity to form a physical barrier between the penis and vagina (previously known as a female condom) |
| external condom | a condom placed over the erect penis before sexual activity to form a physical barrier (previously known as a male condom) |
| phosphodiesterase-5 inhibitor | any of the class of drugs most frequently used to treat erectile dysfunction |
| hirsutism | abnormal hairiness |
| estrogen | any of the group of hormones produced primarily in the ovaries that regulate the reproductive system and produce typically feminine secondary sex characteristics |